Vimarsana
Biggest News Aggregation in the World

Page 8 - General Plastic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from General Plastic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In General Plastic Today - Breaking & Trending Today

Vidal Says Discretionary Denials Don't Doom Serial Petitions - Vimarsana News

Vidal Says Discretionary Denials Don't Doom Serial Petitions

When the Patent Trial and Appeal Board uses its discretion to deny a patent challenge, future challenges to the same patent shouldn't be automatically denied, particularly if the merits haven't been evaluated, U.S. Patent and Trademark Office Director Kathi Vidal said Tuesday.

Source: law360.com
PTAB Updates: Director Vidal Grants Director Review, Sets Schedule And Authorizes Amicus Briefing - Patent - Vimarsana News

PTAB Updates: Director Vidal Grants Director Review, Sets Schedule And Authorizes Amicus Briefing - Patent

On July 7, 2022, Director Kathi Vidal granted Director review of the PTAB decisions in OpenSky Industries, LLC v. VLSI Technology LLC, IPR2021-01064, Paper 47 (PTAB July 7, 2022) and Patent Quality Assurance, LLC v. VLSI Technology LLC, IPR2021-01229, Paper 35 (PTAB July 7, 2022).

Source: mondaq.com
Navigating a decade of the America Invents Act - Vimarsana News

Navigating a decade of the America Invents Act

Ken Korea, principal at Colev Law and former head of Silicon Valley IP at Samsung, delves into the history and future of the Patent Trial and Appeal Board

Substantive Grounds in PTAB Litigation - Vimarsana News

Substantive Grounds in PTAB Litigation

Patent Trial and Appeal Board in OpenSky Indus., LLC v. VLSI Tech. LLC analyzed OpenSky’s Petition under §314d and §325d, declining to deny institution, finding, in part, that since Fintiv and General Plastic did not warrant discretionary denial.

PTAB Agrees to Review Novartis' Patent for an Ophthalmic Injection Syringe | Rothwell, Figg, Ernst & Manbeck, P.C. - Vimarsana News

PTAB Agrees to Review Novartis' Patent for an Ophthalmic Injection Syringe | Rothwell, Figg, Ernst & Manbeck, P.C.

On October 26, 2021, the Patent Trial and Appeal Board (PTAB) granted Regeneron’s petition to institute an inter partes review (IPR) of Novartis’s patent U.S. Pat. No. 9,220,631 (“the...